Our CHM 0201 Vactosertib trial has seen a few changes last week:
https://clinicaltrials.gov/study/NCT05400122?tab=history&a=9&b=10#version-content-panel
The conditions has seen a few additional inclusions:
Vactosertib will now only be administered once (instead of twice) "daily for 5 consecutive days per week, for up to four weeks total."
The inclusion criteria have also been updated.
Lets see what impact this has on the recruitment numbers of the next few months (estimated primary completion date is still 31/12/2025).
Ann: 1st patient dosed in CHM 0201 Vactosertib trial, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.045M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $22.28K | 6.311M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 78 | 84735861 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 86304338 | 23 |
View Market Depth
| Last trade - 14.27pm 25/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |